No OS difference between DAS/D and PBO/D (median, 21.5 vs. 21.2 mos; hazard ratio [HR], 0.99; log-rank P = 0.90) was observed. Results of secondary endpoints for DAS/D vs. PBO/D were: ORR (30.5 vs. 31.9%); TFSRE (median, not reached vs. 31.1 mos; HR, 0.81 [95% CI, 0.64-1.02]); uNTX reduction (66.0 vs. 60.6%); PFS (median, 11.8 vs. 11.1 mos; HR, 0.92); TPSAP (median, 8.0 vs. 7.6 mos; HR, 0.91), and pain reduction (66.6 vs. 71.5%). Twenty-three percent of DAS/D and 14% of PBO/D pts received therapy for
I created this account when I was in my late teens/early 20's. I originally started account to play card games like spades.(card games have a calming affect on me) First letter of last name, term to describe my wild reckless behaviors at the time, zip code.
"you work in the nuke industry? my graduate degree is in cellular/molecular radiation bio - loads of nuclear phiz."
Yes, I graduated with Associate's in height of the nuclear cardiology boom.